Diabetes Control and Cardiovascular Risk: ACCORD, ADVANCE, AVOID, and SANDS
- PMID: 19476576
- DOI: 10.1111/j.1751-7141.2008.00006.x
Diabetes Control and Cardiovascular Risk: ACCORD, ADVANCE, AVOID, and SANDS
Comment on
-
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.JAMA. 2008 Apr 9;299(14):1678-89. doi: 10.1001/jama.299.14.1678. JAMA. 2008. PMID: 18398080 Free PMC article. Clinical Trial.
-
Aliskiren combined with losartan in type 2 diabetes and nephropathy.N Engl J Med. 2008 Jun 5;358(23):2433-46. doi: 10.1056/NEJMoa0708379. N Engl J Med. 2008. PMID: 18525041 Clinical Trial.
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6. N Engl J Med. 2008. PMID: 18539916 Clinical Trial.
-
Effects of intensive glucose lowering in type 2 diabetes.N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6. N Engl J Med. 2008. PMID: 18539917 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources